欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
PT/H/1441/004
药品名称
Olmesartan + Hidroclorotiazida Zidrium
活性成分
Hydrochlorothiazide 25.0 mg
Olmesartan medoxomil 40.0 mg
剂型
Film-coated tablet
上市许可持有人
Teva Pharma - Produtos Farmacêuticos, Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Germany (DE)
Olmesartan comp. ratiopharm 40 mg/25 mg Filmtabletten
Luxembourg (LU)
Olmesartan comp. ratiopharm, 40 mg / 25 mg, Comprimé pelliculé
许可日期
2016/04/27
最近更新日期
2024/10/08
药物ATC编码
C09DA08 olmesartan medoxomil and diuretics
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
PubAR
|
598168_508169_598166_598167_20160609_PAR_ACM
Date of last change:2024/09/06
Final Product Information
|
common_labelling_20mg
Date of last change:2024/09/06
Final Product Information
|
common_labelling_40mg
Date of last change:2024/09/06
Final Product Information
|
common_pl_clean20mg
Date of last change:2024/09/06
Final Product Information
|
common_pl_clean40mg
Date of last change:2024/09/06
Final Product Information
|
common_spc_clean20mg
Date of last change:2024/09/06
Final Product Information
|
common_spc_clean40mg
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase